Divergent expression of L-type amino acid transporter 1 during uterine cervical carcinogenesis

• Published in: Human pathology 2011-11, Vol.42 (11), p.1660-1666
• Main Authors: Uno, Kaname, Medical Student, Kuwabara, Haruki, Medical Student, Terado, Yuichi, MD, Kojima, Kaoruko, CT, Kawakami, Tomohiro, MD, Kamma, Hiroshi, MD, Sakurai, Hiroyuki, MD, Sakamoto, Atsuhiko, MD, Kurata, Atsushi, MD
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - metabolism; Adenocarcinoma - pathology; Amino acids; Biological and medical sciences; Biomarkers, Tumor - metabolism; Carcinoma, Squamous Cell - metabolism; Carcinoma, Squamous Cell - pathology; Cell growth; Cervical cancer; Cervical Intraepithelial Neoplasia - metabolism; Cervical Intraepithelial Neoplasia - pathology; Cervical Intraepithelial Neoplasia - virology; Cloning; Differential diagnosis; Female; Female genital diseases; Gynecology. Andrology. Obstetrics; Human papillomavirus; Humans; Immunohistochemistry; Infectious diseases; Investigative techniques, diagnostic techniques (general aspects); Ki-67 Antigen - metabolism; L-type amino acid transporter 1; Large Neutral Amino Acid-Transporter 1 - biosynthesis; Medical sciences; Pathology; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Rodents; Tomography; Tumors; Uterine cervical neoplasm; Uterine Cervical Neoplasms - metabolism; Uterine Cervical Neoplasms - pathology; Viral diseases
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/j.humpath.2011.01.013

Summary L-type amino acid transporter 1 (LAT1) is a Na+ –independent neutral amino acid transporter that has an essential role in cell proliferation. Although LAT1 expression is observed in various tumor cell lines and immunohistochemical expression of LAT1 has been investigated in carcinomas of various organs, LAT1 expression in uterine cervical neoplasm has not been reported. Therefore, in the present study, we immunohistochemically analyzed LAT1 expression along with the well-known markers of cervical carcinogenesis Ki-67 and p16 in normal uterine cervical mucosa (49 specimens) as well as cervical intraepithelial neoplasia (17 mild or moderate dysplasias and 19 severe dysplasias or carcinomas in situ) and invasive carcinomas (17 squamous cell carcinomas and 9 adenocarcinomas). LAT1 expression was limited to the basal layer of normal squamous epithelium, and it was significantly decreased in cervical intraepithelial neoplasia ( P < .001), generally paralleled by increased expression of Ki-67 and p16. Interestingly, in invasive squamous cell carcinoma, LAT1 expression again increased especially at the invasive fronts ( P < .001), whereas Ki-67 and p16 expressions were almost unchanged relative to noninvasive neoplasia. Although virtually no LAT1 expression was demonstrated in normal uterine cervical glands, LAT1 expression was observed in some adenocarcinomas ( P < .001). The present study suggests that LAT1 expression decreases because of human papillomavirus infection as reflected by p16 overexpression in cervical intraepithelial neoplasia, whereas LAT1 expression in invasive carcinoma is associated with acquired malignant potential.